Semax Peptide
A seven-residue fragment built in Moscow, sold in Russian pharmacies as nasal drops, and listed among that country's Vital and Essential Medicines. The Western file on it is nearly empty. Both facts are true at once.
Choose your pack
For research use only. Not for human or veterinary use.
What Semax Peptide is
The plain-language version, first.
A stress hormone fragment with the stress cut out of it.
It is studied as an ACTH (4-10) analog, primarily for effects on BDNF and cognition in animal models, with clinical use largely confined to Russia.
Here's a fun way to build a compound. Take a hormone everybody knows, snip out a middle piece, and discover the piece does something the hormone doesn't.
ACTH is your body's stress messenger. It tells the adrenals to make cortisol.
Semax is four residues of ACTH with a three-residue tail welded on, and it does not touch your adrenals at all.
The fragment kept the brain-facing activity and dropped the hormonal job entirely, which is exactly the sort of result that makes fragment research worth doing.
Built at Moscow's Institute of Molecular Genetics, and it never really left home.
In Russia it is a pharmacy product. In the West it is a curiosity. Same molecule, two completely different lives.
What Semax peptide actually does
Mechanism studied, not outcome promised.
Semax keeps ACTH residues 4 to 7 and replaces 8 to 10. FDA describes it as devoid of the corticotropic and melanotropic activity of the parent hormone.
Proline-rich sequences are poor peptidase substrates, so the tail extends half-life, and it appears to contribute to activity in its own right.
Take ACTH, keep four residues, weld on a stabiliser, lose the hormone part.
The proposed story runs through the brain's own maintenance signals, particularly one called BDNF, which is roughly the molecule your neurons use to encourage each other.
The animal work points at Semax nudging that system, along with dopamine and serotonin signalling.
Nudging the encouragement system is a genuinely interesting mechanism. It is also a mechanism established mostly in Russian laboratories and rodents.
The nasal-drop format is not a gimmick, incidentally. It is a real answer to the problem that peptides do not survive stomachs, and the nose is a surprisingly direct route.
Here's the honest part. Most of the mechanistic work has a single national address.
Nothing wrong with Moscow's laboratories. But replication means somebody else, somewhere else, and that column is close to empty.
The research so far for Semax Peptide
Where the evidence is thin, we say so.
Two substantial Russian clinical studies in ischaemic stroke, 30 patients against 80 controls in 1997 and 110 post-stroke patients in 2018 measuring plasma BDNF and functional scales, plus domestic registration and essential-medicines listing.
Randomised blinded trials, trial registry entries, human pharmacokinetic data for any route, English translations, and any assessment by the FDA, EMA or Health Canada.
Semax appears in the Russian Federation List of Vital and Essential Medicines under Government Decree 2406-r of 12 October 2019, in the nervous system section, ATC class N06BX, as nasal drops. When FDA reviewed it in July 2026 it excluded the Russian-language studies because its regulation requires verified English translations, leaving one conference abstract with no clinical endpoints reported.
Two regulatory worlds looked at this and one of them never really looked.
The strangest thing about Semax is its paperwork.
It is listed among Russia's Vital and Essential Medicines, prescribed there for decades, with a substantial Russian-language clinical literature behind it.
Western regulators have never assessed it. Not rejected.
Never assessed. It simply never crossed the desk.
And the Russian trials, read carefully, were largely run without placebo controls, which by modern Western convention is the load-bearing feature.
Nothing approved outside Russia and its neighbours. No Western randomised trial.
A compound with a twenty-year prescription history in one country and essentially no file in yours. That mismatch is the single most important thing to know about it.
Semax 5mg lyophilised. Ships same day out of BC.
Semax Peptide specs
The chemistry, exactly as released.
Who studies Semax Peptide
Who tends to order this one, and why.
A research compound does not have one audience. It has a handful of rooms where the same question keeps coming up, and the question is a different question in each of them.
Stroke medicine
Both substantial human studies are in ischaemic stroke, one in the acute period and one in rehabilitation, measuring motor scales and functional independence.
Neurotrophin research
BDNF is the most cited mechanism, and the 2018 study measured plasma BDNF directly rather than relying on symptom scores alone.
Melanocortin neuroscience
Central melanocortin receptors are involved in attention, arousal and neuroprotection quite separately from the adrenal axis. Semax is built on exactly that separation.
Russian peptide pharmacology
A decades-long tradition of developing short regulatory peptides as drugs, which also produced Selank from tuftsin using the same stabilising extension.
Sold for laboratory research only. This is not guidance for personal use, and nothing here is a recommendation.
Semax Peptide backstory
How it got here.
Soviet and Russian peptide research followed its own path for decades, largely disconnected from Western pharmaceutical development, with a particular focus on short regulatory peptides as drugs. Two institutes in Moscow drove it: the Institute of Molecular Genetics and the Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry.
That tradition produced Semax from ACTH and Selank from tuftsin, both using the same Pro-Gly-Pro stabilising trick, both registered domestically, both essentially unknown to regulators elsewhere. Semax went further than most.
It reached the List of Vital and Essential Medicines, which is the Russian state's designation for drugs considered necessary for public healthcare, and it has been in clinical use as nasal drops for stroke and cognitive indications for years. The language barrier is a substantial part of why it stayed regional.
A clinical literature published in Russian in Russian journals does not cross into Western regulatory review, which requires verified translations that nobody has commissioned.
- 1
A hormone that did more than one job
ACTH drives cortisol release, but its 4 to 10 fragment showed effects on learning and attention that had nothing to do with the adrenal glands.
- 2
Keep the brain part, drop the hormone part
Retain residues 4 to 7, replace 8 to 10 with Pro-Gly-Pro, and you get central activity without corticotropic activity. That is the design premise.
- 3
Essential at home, unknown abroad
Registered in Russia as nasal drops and listed among Vital and Essential Medicines, while remaining unassessed by every Western regulator.
Buying Semax Peptide in Canada
What ships, how fast, and the paperwork.
The hard part of buying research material is almost never the compound. It is the logistics. What leaves the building, how fast it moves, and what is in the box beside the vial. Here is ours, plainly.
Every human study used the nose
The Russian registered product is nasal drops at 0.1 and 1 percent, and all published human use is intranasal. FDA noted it could not locate human pharmacokinetic studies for any route. There is no published human data for subcutaneous Semax.
Same day out of British Columbia
Our building, our cold packs, our people, and nothing sitting in a customs queue while you refresh a tracking page.
Anti-doping status is genuinely unsettled
Semax is not named on the WADA 2026 list, and the S0 catch-all arguably does not apply because it is approved by a governmental health authority in Russia. Whether S2.2.2, corticotrophins and their releasing factors, captures an ACTH fragment analogue described as devoid of corticotropic activity is not resolved by the text. A tested athlete needs a written ruling from their anti-doping organisation, not a retailer opinion.
Semax Peptide vs Selank
Stacked together constantly, compared almost never.
Same Moscow institute, same era, same stabilising tail welded on. These two are labmates, and comparing them is mostly a question of which hormone got clipped.
Semax starts from ACTH, the stress messenger, keeping four residues of it. The interest went toward BDNF signalling and the attention side of brain chemistry.
Selank starts from tuftsin, an immune peptide, and the interest went the other way, toward GABA signalling and the calm side.
Two fragments, one lab, opposite directions. Both share the same file problem: substantial Russian clinical use, almost no placebo-controlled work, and no Western regulator has ever assessed either. Selank has its own page here
Stuff people ask about Semax Peptide
If your question is not here, email us. Real human answers.
In Russia, yes. It is registered as nasal drops at 0.1 and 1 percent and appears in the Russian Federation List of Vital and Essential Medicines under Government Decree 2406-r of 12 October 2019, in the nervous system section, ATC class N06BX, alongside piracetam and vinpocetine. It has never been assessed or approved by the FDA, the EMA or Health Canada.
It is a seven residue analogue of the ACTH 4-10 fragment. It retains ACTH residues 4 to 7, Met-Glu-His-Phe, and replaces residues 8 to 10 with a C-terminal Pro-Gly-Pro extension. FDA describes it as devoid of the corticotropic and melanotropic hormone activity of the parent, which was the point of the design.
Two substantial Russian studies. Gusev and colleagues in 1997 enrolled 30 patients in acute hemispheric ischaemic stroke against 80 controls on conventional therapy, not randomised or blinded. The same group in 2018 followed 110 post-stroke patients, measuring plasma BDNF, the MRC motor scale and the Barthel index, reporting higher BDNF and better functional scores. Same group, same country, no independent replication. Neither is on a trial registry.
Because its own regulation, 21 CFR 10.20(c)(2), requires a verified English translation for a foreign-language document to be considered. The Russian-language papers were excluded on that basis, leaving one English conference abstract that reported no clinical endpoints. FDA recommended against adding Semax to the compounding list; its advisory committee voted 8 to 5 the other way, and those votes are non-binding.
Intranasal, in every published human study, and the Russian registered product is nasal drops. FDA stated it was not able to find pharmacokinetic studies in humans for any route. There is no published human data for subcutaneous administration.
Genuinely unclear, and we are not going to pretend otherwise. It is not named on the WADA 2026 Prohibited List. The S0 catch-all for non-approved substances arguably does not apply, because Semax is approved by a governmental regulatory health authority in Russia. Whether section S2.2.2, corticotrophins and their releasing factors, captures an ACTH fragment analogue characterised as devoid of corticotropic activity is not settled by the wording. If you are tested, get a written ruling from your anti-doping organisation.
Good pairing options with Semax Peptide
What researchers stack alongside it.
Pairing is where research gets ahead of itself. These are the compounds researchers put in the same order as Semax Peptide, which is a statement about ordering habits, not about evidence. Two things in one cart have not been studied together unless somebody studied them together.
Seven residues that shut a potassium channel called TREK-1. One laboratory, one paper, and a number so striking that the right response is to wait for somebody else to see it too.
A peptide preparation made from pig brain, used in clinics across half the world. A 2023 Cochrane review found no mortality benefit and a 2.39 relative risk of serious adverse events. We are leading with that on purpose.
Order Semax Peptide right now
One last look before you decide.
Freeze-dried, COA on the page, ships cold
If you are researching Semax Peptide and you want a source you do not have to second-guess, start with the paperwork on this page. For research use only.
Not for human consumption. Not approved by Health Canada or any other regulatory body.
Page last updated August 19, 2026
People also search for Semax Peptide
Other names for the same compound.